Expert Rev Endocrinol Metab January 2021 PMID 33345656

Human chorionic gonadotropin treatment: a viable option for management of secondary hypogonadism and male infertility.

Julius Fink, Brad J Schoenfeld, Anthony C Hackney, Takahiro Maekawa, Shigeo Horie

Download social card

Mentions

4
Peak: 1 in Dec 2020
across 3 sources since Dec 2020

Extended reach

2,568
potential audience

Total likes

55

Video views

623

Mentions per month

Dec 2020 – Apr 2025

Where it's discussed

  • News2 articles
  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

The comments indicate a casual approach to the publication, with phrases such as 'limiting endocrine repertoire' suggesting a humorous tone and a recognition of the ongoing exploration of treatments like HCG. The overall tone shows moderate curiosity but not intense enthusiasm or critical analysis, reflecting a general acknowledgment of the study's relevance without emphasizing its broader implications.

AgreementNeither agree nor disagree

The shared tone indicates mild amusement or acknowledgment rather than strong support or disagreement with the publication's findings.

InterestModerate interest

The discussion shows some curiosity about treatment options for hypogonadism, considering the publication as part of ongoing research, but overall interest remains relatively modest.

EngagementModerate engagement

Comments reflect an attempt to connect the article to broader endocrine topics, indicating basic engagement rather than deep analysis.

ImpactNeutral impact

The discussion does not suggest the publication has a significant immediate impact or transformative effect on the community's views.

Abstract in brief

  • Human chorionic gonadotropin (HCG) is an effective alternative treatment for secondary hypogonadism and male infertility, as it stimulates testosterone and sperm production without harming fertility.
  • Recent research from 1977 to 2020 highlights that HCG can boost testosterone levels and improve symptoms associated with low testosterone, while avoiding the infertility risks linked to traditional testosterone replacement therapy.
  • HCG offers a promising option for managing low testosterone in men, providing the benefits of hormone therapy without the negative impact on male fertility seen with some other treatments.

Top posts

Most liked on X and Bluesky
AC Hackney
@AC_Hackney · X

Started the year with an article on male #hypogonadism and exercise in an endocrine journal, and now ending the year with an article on treating hypogonadism in an endocrine journal - Sorry, I obviously have a limited endocrine repertoire. https://t.co/qm1kvodW8n

Dec 13, 2020 · 17 likes · 1,946 followers View post →

All mentions

AC Hackney
@AC_Hackney · X

Started the year with an article on male #hypogonadism and exercise in an endocrine journal, and now ending the year with an article on treating hypogonadism in an endocrine journal - Sorry, I obviously have a limited endocrine repertoire. https://t.co/qm1kvodW8n

Dec 13, 2020 · 17 likes · 1,946 followers View post →